cimetidine 400mg tablets
tillomed laboratories ltd - cimetidine - oral tablet - 400mg
cimetidine 200mg tablet, film coated
medical generics mktg co., - cimetidine - tablet, film coated - 200mg
cimetidine 200mg tablet
biotech research labs inc - cimetidine - tablet - 200mg
cimetidine 200mg oral solid ordinary tablets
umedica laboratories pvt ltd - cimetidine - oral solid ordinary tablets - 200mg
apo-cimetidine oral solution liquid
apotex inc - cimetidine (cimetidine hydrochloride) - liquid - 300mg - cimetidine (cimetidine hydrochloride) 300mg - histamine h2-antagonists
apo-cimetidine
apotex nz ltd - cimetidine 400mg; ; cimetidine 400mg - film coated tablet - 400 mg - active: cimetidine 400mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose hypromellose macrogol 8000 magnesium stearate microcrystalline cellulose titanium dioxide active: cimetidine 400mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose ferric oxide as macrogol 3350 magnesium stearate microcrystalline cellulose quinoline yellow titanium dioxide - conditions where the reduction of gastric acid secretion is beneficial e.g. treatment of duodenal and benign ulceration, gastro-oesophageal reflux disease, recurrent ulceration of the upper gastrointestinal tract, stomal ulceration, persistent non-ulcer dyspepsia and the short-term treatment of dyspepsia or pain associated with hyperacidity. prevention of the recurrence of duodenal or benign gastric ulcers in patients who have a history of recurrence or complications or for whom surgery is contraindicated. prevention of stress ulcer in patients at risk of haemorrhage, the management of pathological hypersecretion e.g. zollinger-ellison syndrome, systemic mastocytosis and multiple endocrine adenomas and the management of haemorrhage due to peptic ulceration or erosions of the upper gastrointestinal tract. reduction of gastric acidity and secretory volume thus reducing the risk of pulmonary damage from aspiration of gastric contents in patients undergoing general anaesthesia. cimetidine can be used in conjunction with a h1 antagonist for the prevention of anaphylactic reaction secondary to histamine release caused by infusion of certain medicines e.g. radiopaque contrast agents and plasma substitutes.
dom-cimetidine tablet
dominion pharmacal - cimetidine - tablet - 300mg - cimetidine 300mg - histamine h2-antagonists
dom-cimetidine tablet
dominion pharmacal - cimetidine - tablet - 400mg - cimetidine 400mg - histamine h2-antagonists
dom-cimetidine tablet
dominion pharmacal - cimetidine - tablet - 600mg - cimetidine 600mg - histamine h2-antagonists
dom-cimetidine tablet
dominion pharmacal - cimetidine - tablet - 800mg - cimetidine 800mg - histamine h2-antagonists